Allergic Fungal Rhinosinusitis Diagnosis, Management, Associated Conditions, Pathophysiology, and Future Directions:

Lauren T Roland1, Cecelia Damask2, Amber U Luong3

  • 1Department of Otolaryngology, Washington University in St Louis, St Louis, Missouri, USA.

Insights

Allergic fungal rhinosinusitis (AFRS) is a severe CRSwNP subtype lacking research. Experts convened to identify key research gaps in AFRS diagnosis, pathophysiology, and management.

Area of Science:

  • Otolaryngology
  • Allergy and Immunology
  • Pulmonology

Background:

  • Allergic fungal rhinosinusitis (AFRS) is a distinct endotype of chronic rhinosinusitis with nasal polyps (CRSwNP).
  • AFRS exhibits high recurrence rates and severe symptoms compared to other CRSwNP subtypes.
  • Significant research gaps exist regarding AFRS, including outdated diagnostic criteria and unclear pathophysiology.

Purpose of the Study:

  • To address the unmet needs in Allergic Fungal Rhinosinusitis (AFRS) research and patient care.
  • To convene a multidisciplinary expert panel to discuss critical aspects of AFRS.
  • To identify future research directions for AFRS diagnosis, management, and understanding.

Main Methods:

  • A multidisciplinary meeting was held in December 2023 at the National Institute of Health.
  • Experts included rhinologists, otolaryngologists, pulmonologists, allergists, immunologists, scientists, and infectious disease specialists.
  • Discussions focused on patient management, diagnostic criteria, disease severity, pathophysiology, and related conditions.

Main Results:

  • Identified outdated diagnostic criteria for AFRS.
  • Highlighted the unclear mechanistic relationship of AFRS to other diseases.
  • Emphasized the need for further study into AFRS pathophysiology and recurrence risk factors.

Conclusions:

  • There is a critical need for dedicated research into Allergic Fungal Rhinosinusitis (AFRS).
  • Future research should focus on refining diagnostic criteria and understanding disease mechanisms.
  • Improved patient management strategies are required for this severe CRSwNP subtype.

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
225
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
242
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
131
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
129